Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > My thoughts on webnar

<< Previous

Bullboard Posts

Next >>

Comment by megaflopon Aug 10, 2023 9:28pm

268 Views

Post# 35583043

RE:My thoughts on webnar

Pelareorep is normally shortened to pela, not paleo. Good synopsis otherwise. Thanks.
Pretty much what I heard too. I do not think they said ONC will try another CI, but a partner or buyer may well want to at some point. Sometime in September we should hear about finalizing the PanCan agreement. More panc and crc results at end of October. Exciting times.

<< Previous

Bullboard Posts

Next >>

What will the U.S. election results mean for Canada?